Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 6/2018

01-12-2018 | Research Article

Knowledge of cardiovascular disease risk factors and practice of primary prevention of cardiovascular disease by Community Pharmacists in Nigeria: a cross-sectional study

Authors: Casmir E. Amadi, Folasade O. Lawal, Amam C. Mbakwem, Jayne N. Ajuluchukwu, David A. Oke

Published in: International Journal of Clinical Pharmacy | Issue 6/2018

Login to get access

Abstract

Background Studies in international literature have shown that Community Pharmacists can make considerable impact in controlling cardiovascular disease risk factors, especially hypertension. In Nigeria, there are no studies on the knowledge of CVD risk factors by Community Pharmacists and their practice of primary prevention. Objective To assess the knowledge of CVD risk factors and practice of primary prevention of CVD amongst Nigerian community pharmacists. Setting Community Pharmacists in Lagos, Nigeria. Methods This cross-sectional study involved 168 Community Pharmacists. Their knowledge of CVD risk factors was assessed with the Heart Disease Fact Questionnaire. Their opportunistic screening practices for CVD risk factors (primary prevention) were also assessed. Main outcome measures Knowledge of CVD risk factors and practice of primary CVD prevention. Results The mean age of the participating pharmacists was 41.7 (± 11.2) years and 87 (51.8%) of them were males. The median number of years of practice was 9.0 (3–15) years. Mean knowledge score was 22.1 (± 3.0) with 154 (91.7%) of the subjects scoring above 70%. An average of 95.5% of the participants correctly identified hypertension, smoking, dyslipidaemia, obesity, physical inactivity and diabetes as CVD risk factors. Eighty-one (48.2%) had good practice of primary CVD prevention. Conclusion: This study shows that Community Pharmacists in Nigeria have very good knowledge level of CVD risk factors and almost 50% of them practised primary prevention of CVD.
Literature
1.
go back to reference World Health Organization. Prevention of cardiovascular disease: guidelines for assessment and management of cardiovascular risk. Geneva, Switzerland; 2007. Accessed 22 July 2015. World Health Organization. Prevention of cardiovascular disease: guidelines for assessment and management of cardiovascular risk. Geneva, Switzerland; 2007. Accessed 22 July 2015.
2.
go back to reference Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367(9524):1747–57.CrossRef Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367(9524):1747–57.CrossRef
3.
go back to reference Bygbjerg IC. Double burden of non-communicable and infectious diseases in developing countries. Science. 2012;337(6101):1499–501.CrossRef Bygbjerg IC. Double burden of non-communicable and infectious diseases in developing countries. Science. 2012;337(6101):1499–501.CrossRef
4.
go back to reference Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: part II. Variation in cardiovascular diseases by specific ethnic groups and geographic regions and preventive strategies. Circulation. 2001;104(23):2855–64.CrossRef Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: part II. Variation in cardiovascular diseases by specific ethnic groups and geographic regions and preventive strategies. Circulation. 2001;104(23):2855–64.CrossRef
5.
go back to reference Steyn K, Sliwa K, Hawken S, Commerford P, Onen C. Risk factors associated with myocardial infarction in Africa: the INTERHEART Africa Study. Circulation. 2005;112:3554–61.CrossRef Steyn K, Sliwa K, Hawken S, Commerford P, Onen C. Risk factors associated with myocardial infarction in Africa: the INTERHEART Africa Study. Circulation. 2005;112:3554–61.CrossRef
6.
go back to reference Adeloye D, Basquill C, Aderemi AV, et al. An estimate of the prevalence of hypertension in Nigeria: a systematic review and meta-analysis. J Hypertens. 2015;33(2):230–42.CrossRef Adeloye D, Basquill C, Aderemi AV, et al. An estimate of the prevalence of hypertension in Nigeria: a systematic review and meta-analysis. J Hypertens. 2015;33(2):230–42.CrossRef
8.
go back to reference Ogbera OA, Ekpebegh C. Diabetes mellitus in Nigeria: the past, present and future. World J Diabetes. 2014;5(6):905–11.CrossRef Ogbera OA, Ekpebegh C. Diabetes mellitus in Nigeria: the past, present and future. World J Diabetes. 2014;5(6):905–11.CrossRef
9.
go back to reference Odeyemi KA, Osibogun A, Akinsele AO, Sadiq L. The prevalence and predictors of cigarette smoking in secondary students in Nigeria. Niger Postgrad Med J. 2009;16:40–5.PubMed Odeyemi KA, Osibogun A, Akinsele AO, Sadiq L. The prevalence and predictors of cigarette smoking in secondary students in Nigeria. Niger Postgrad Med J. 2009;16:40–5.PubMed
10.
go back to reference Akaralo-Anthony SN, Adebamowo CA. Prevalence and correlates of leisure-time physical activity among Nigerians. BMC Public Health. 2014;14:529.CrossRef Akaralo-Anthony SN, Adebamowo CA. Prevalence and correlates of leisure-time physical activity among Nigerians. BMC Public Health. 2014;14:529.CrossRef
12.
go back to reference Ogundamola OJ, Oladosun OY. Pattern and outcomes of admissions in the medical wards of a tertiary health centre in a rural community of Ekiti State, Nigeria. Ann Afr Med. 2014;13:195–203.CrossRef Ogundamola OJ, Oladosun OY. Pattern and outcomes of admissions in the medical wards of a tertiary health centre in a rural community of Ekiti State, Nigeria. Ann Afr Med. 2014;13:195–203.CrossRef
13.
go back to reference Oguanobi NI, Ejim EC, Onwubere BJ, Ike SO, Anisiuba BC, Ikeh VO, Aneke EO. Pattern of cardiovascular disease amongst medical admissions in a regional teaching hospital in South-eastern Nigeria. Niger J Cardiol. 2013;10:77–80.CrossRef Oguanobi NI, Ejim EC, Onwubere BJ, Ike SO, Anisiuba BC, Ikeh VO, Aneke EO. Pattern of cardiovascular disease amongst medical admissions in a regional teaching hospital in South-eastern Nigeria. Niger J Cardiol. 2013;10:77–80.CrossRef
14.
go back to reference Schwappach D, Boluarte T, Suhrcke M. The economics of primary prevention of cardiovascular disease—a systematic review of economic evaluations. Cost Eff Resour Alloc. 2007;5(1):5.CrossRef Schwappach D, Boluarte T, Suhrcke M. The economics of primary prevention of cardiovascular disease—a systematic review of economic evaluations. Cost Eff Resour Alloc. 2007;5(1):5.CrossRef
15.
go back to reference Ferdinand KC, Patterson KP, Taylor C, Fergus IV, Nasser SA. Community-based approaches to prevention and management of hypertension and cardiovascular disease. J Clin Hypertens (Greenwich). 2012;14:336–43.CrossRef Ferdinand KC, Patterson KP, Taylor C, Fergus IV, Nasser SA. Community-based approaches to prevention and management of hypertension and cardiovascular disease. J Clin Hypertens (Greenwich). 2012;14:336–43.CrossRef
16.
go back to reference Machado M, Bajcar J, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions. Part II: systematic review and meta-analysis in hypertension management. Ann Pharmacother. 2007;41(11):1770–81.CrossRef Machado M, Bajcar J, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions. Part II: systematic review and meta-analysis in hypertension management. Ann Pharmacother. 2007;41(11):1770–81.CrossRef
17.
go back to reference Blenkinsopp A, Anderson C, Armstrong M. Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease. J Public Health. 2003;25(2):144–53.CrossRef Blenkinsopp A, Anderson C, Armstrong M. Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease. J Public Health. 2003;25(2):144–53.CrossRef
18.
go back to reference Morgado M, Rolo S, Castelo-Branco M. Pharmacist intervention to enhance hypertension control: a randomised controlled trial. Int J Clin Pharm. 2011;33(1):132–40.CrossRef Morgado M, Rolo S, Castelo-Branco M. Pharmacist intervention to enhance hypertension control: a randomised controlled trial. Int J Clin Pharm. 2011;33(1):132–40.CrossRef
19.
go back to reference George J, McNamara GJ, Stewart K. The roles of community pharmacists in cardiovascular disease prevention and management. AMJ. 2011;4(5):266–72.CrossRef George J, McNamara GJ, Stewart K. The roles of community pharmacists in cardiovascular disease prevention and management. AMJ. 2011;4(5):266–72.CrossRef
20.
go back to reference Santschi VS, Colosimo AL, Chilero A, Burnand B, Paradis G. Pharmacists interventions to improve cardiovascular risk factors in diabetes. a systematic review and meta-analysis. Diabetes Care. 2012;35:2706–17.CrossRef Santschi VS, Colosimo AL, Chilero A, Burnand B, Paradis G. Pharmacists interventions to improve cardiovascular risk factors in diabetes. a systematic review and meta-analysis. Diabetes Care. 2012;35:2706–17.CrossRef
21.
go back to reference Araoye MO. Sample size determination. In: Research methodology with statistics for health and social sciences. 1st Ed. Ilorin: Nathadex Publishers; 2004. p. 115–20. Araoye MO. Sample size determination. In: Research methodology with statistics for health and social sciences. 1st Ed. Ilorin: Nathadex Publishers; 2004. p. 115–20.
22.
go back to reference Wagner J, Lacey K, Chyun D, Abbot D. Development of a questionnaire to measure heart disease risk knowledge in people with diabetes. The Heart Disease Facts Questionnaire. Patient Educ Couns. 2005;58:82–7.CrossRef Wagner J, Lacey K, Chyun D, Abbot D. Development of a questionnaire to measure heart disease risk knowledge in people with diabetes. The Heart Disease Facts Questionnaire. Patient Educ Couns. 2005;58:82–7.CrossRef
23.
go back to reference Wagner J, Lacey K, Chyun D, Abbot D. Knowledge of heart disease risks among Spanish speakers with diabetes. The role of interpreters in the medical encounter. Ethn Dis. 2005;15:679–84.PubMed Wagner J, Lacey K, Chyun D, Abbot D. Knowledge of heart disease risks among Spanish speakers with diabetes. The role of interpreters in the medical encounter. Ethn Dis. 2005;15:679–84.PubMed
24.
go back to reference Akintunde AA, Akintunde TS, Opadijo OG. Knowledge of heart disease risk factors among workers in a Nigerian University. A call for concern. Niger Med J. 2015;56(2):91–5.CrossRef Akintunde AA, Akintunde TS, Opadijo OG. Knowledge of heart disease risk factors among workers in a Nigerian University. A call for concern. Niger Med J. 2015;56(2):91–5.CrossRef
25.
go back to reference Joyce A, Berbatis C, Sunderland VB. Analysis of primary prevention services for cardiovascular disease in Australia’s community pharmacies. Aust N Z J Public Health. 2007;31:516–9.CrossRef Joyce A, Berbatis C, Sunderland VB. Analysis of primary prevention services for cardiovascular disease in Australia’s community pharmacies. Aust N Z J Public Health. 2007;31:516–9.CrossRef
26.
go back to reference Jahangard-Rafsanjani Z, Hakimzadeh N, Sarayani A, Najafi S, Heidari K, Javadi MR, Hadjibabaie M, Gholami K. A community pharmacy-based cardiovascular risk screening service implemented in Iran. Pharm Pract. 2017;15(2):919–25.CrossRef Jahangard-Rafsanjani Z, Hakimzadeh N, Sarayani A, Najafi S, Heidari K, Javadi MR, Hadjibabaie M, Gholami K. A community pharmacy-based cardiovascular risk screening service implemented in Iran. Pharm Pract. 2017;15(2):919–25.CrossRef
27.
go back to reference Via-Sosa MA, Toro C, Trave P, March MA. Screening premorbid metabolic syndrome in community pharmacies: a cross-sectional descriptive study. BMC Public Health. 2014;14:487.CrossRef Via-Sosa MA, Toro C, Trave P, March MA. Screening premorbid metabolic syndrome in community pharmacies: a cross-sectional descriptive study. BMC Public Health. 2014;14:487.CrossRef
28.
go back to reference Willis A, Rivers P, Gray LJ, Davies M, Khunti K. The effectiveness of screening for diabetes and cardiovascular disease risk factors in a community pharmacy setting. PLoS ONE. 2014;9(4):e91157.CrossRef Willis A, Rivers P, Gray LJ, Davies M, Khunti K. The effectiveness of screening for diabetes and cardiovascular disease risk factors in a community pharmacy setting. PLoS ONE. 2014;9(4):e91157.CrossRef
29.
go back to reference Horgan JMP, Blenkinsopp A, McManus RJ. Evaluation of cardiovascular opportunistic risk assessment pilot (‘Heart MOT’ service) in community pharmacies. J Public Health. 2010;32(1):110–6.CrossRef Horgan JMP, Blenkinsopp A, McManus RJ. Evaluation of cardiovascular opportunistic risk assessment pilot (‘Heart MOT’ service) in community pharmacies. J Public Health. 2010;32(1):110–6.CrossRef
30.
go back to reference O’Donovan DO, Byre S, Sahm LJ. Pharmacists use of screening tools to estimate risk of CVD: a review of the literature. Pharmacy. 2014;2:27–39.CrossRef O’Donovan DO, Byre S, Sahm LJ. Pharmacists use of screening tools to estimate risk of CVD: a review of the literature. Pharmacy. 2014;2:27–39.CrossRef
31.
go back to reference Rohla M, Haberfeld H, Sinzinger H, et al. Systematic screening for cardiovascular risk in pharmacies. Open Heart. 2016;3:e000497.CrossRef Rohla M, Haberfeld H, Sinzinger H, et al. Systematic screening for cardiovascular risk in pharmacies. Open Heart. 2016;3:e000497.CrossRef
32.
go back to reference Taylor J, Krska J, Mackridge A. A community pharmacy-based cardio-vascular screening service: views of service users and the public. Int J Pharm Pract. 2012;20:277–84.CrossRef Taylor J, Krska J, Mackridge A. A community pharmacy-based cardio-vascular screening service: views of service users and the public. Int J Pharm Pract. 2012;20:277–84.CrossRef
33.
go back to reference Hindi AMK, Schafheutle EI, Jacobs S. Patients and public perspectives of community pharmacies in the UK: a systematic review. Health Expect. 2018;21:409–28.CrossRef Hindi AMK, Schafheutle EI, Jacobs S. Patients and public perspectives of community pharmacies in the UK: a systematic review. Health Expect. 2018;21:409–28.CrossRef
34.
go back to reference Chiazor EI, Evans M, van Worden H, Oparah AC. A systematic review of community pharmacists’ interventions in reducing major risk factors for cardiovascular disease. J Value Health Reg Issues. 2015;7c:9–21.CrossRef Chiazor EI, Evans M, van Worden H, Oparah AC. A systematic review of community pharmacists’ interventions in reducing major risk factors for cardiovascular disease. J Value Health Reg Issues. 2015;7c:9–21.CrossRef
35.
go back to reference Jahangard-Rafsanjani Z, Sarayani A, Javadi MR, Hadjibabaie M, Rashidian A, Ahmadvand A, et al. Pharmacists’ attitudes and perceived barriers about community pharmacy-based cardiovascular risk screening services. J Pharm Care. 2014;2(4):142–8. Jahangard-Rafsanjani Z, Sarayani A, Javadi MR, Hadjibabaie M, Rashidian A, Ahmadvand A, et al. Pharmacists’ attitudes and perceived barriers about community pharmacy-based cardiovascular risk screening services. J Pharm Care. 2014;2(4):142–8.
36.
go back to reference Kotecki JE, Elanjian SI, Torabi MR. Health promotion beliefs and practices amongst pharmacists. J Am Pharm Asso. 2000;40:773–9. Kotecki JE, Elanjian SI, Torabi MR. Health promotion beliefs and practices amongst pharmacists. J Am Pharm Asso. 2000;40:773–9.
37.
go back to reference Uema SA, Vega EM, Armando PD, Fontana D. Barriers to pharmaceutical care in Argentina. Pharm World Sci. 2008;30:211–5.CrossRef Uema SA, Vega EM, Armando PD, Fontana D. Barriers to pharmaceutical care in Argentina. Pharm World Sci. 2008;30:211–5.CrossRef
Metadata
Title
Knowledge of cardiovascular disease risk factors and practice of primary prevention of cardiovascular disease by Community Pharmacists in Nigeria: a cross-sectional study
Authors
Casmir E. Amadi
Folasade O. Lawal
Amam C. Mbakwem
Jayne N. Ajuluchukwu
David A. Oke
Publication date
01-12-2018
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 6/2018
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-018-0744-3

Other articles of this Issue 6/2018

International Journal of Clinical Pharmacy 6/2018 Go to the issue